• Ms.Amy Lu
    Tel: 027-84306245

  • Mobile:
  • Tel:027-84306245
  • Fax:
  • URL:http://www.wondapharm.com
  • Province/state:Hubei
  • City:Wuhan
  • Street:Wuhan Private Science and Technology Park , Wuhan, China
  • MaxCard:
Home > Products >  Pharmaceutical Grade CAS 475207-59-1 Sorafenib tosylate Anticancer

Pharmaceutical Grade CAS 475207-59-1 Sorafenib tosylate Anticancer CAS NO.475207-59-1

  • Min.Order: 10 Gram
  • Payment Terms: T/T,MoneyGram
  • Product Details

Keywords

  • Sorafenib tosylate
  • Sorafenib tosylate powder
  • CAS 475207-59-1

Quick Details

  • ProName: Pharmaceutical Grade CAS 475207-59-1 S...
  • CasNo: 475207-59-1
  • Molecular Formula: C21H16ClF3N4O3
  • Appearance: white powder
  • Application: approved for the treatment of primary ...
  • DeliveryTime: immediately after payment receives
  • PackAge: discreet packing
  • Port: HK, Shanghai, Shenzhen
  • ProductionCapacity: 500 Kilogram/Month
  • Purity: 99%
  • Storage: cool and dry place
  • Transportation: email:wonda-chem@outlook.com
  • LimitNum: 10 Gram

Superiority

1.high quality:

quality is life. quality is the most important element for all goods. we have a lab doing research in wuhan china. hplc and nmr is available if needed.

2.reasonable price:

we provide high quality products with competitive price in china. all customers are welcomed to send us inquiries and get quotation.

3.low moq:

no worry about the low moq, our moq is 1 gram or even lower.

4.good service.

fast response. we promise to reply within 24 hours including holidays and send quotation sheet and other documents within 48 hours.

5. fast shipping and secure courier.

we promise to send out products and provide tracking number within 3 working days. and we send via different couriers based on different destination countries. we usually use nl post, hk post, germany post, eub, etk, etc.

 

Details

 

Product name:Sorafenib tosylate
Synonyms:Sorafenib tosylate
CAS No.:475207-59-1
Molecular formula:C21H16ClF3N4O3.C7H8SO3 
Molecular weight:637.03 

 

Usage:

 

Sorafenib is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma. 

 

 

 

 

Packing and shipping

 

 

 

 

 

 

 

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog